IP Group, founded in 2001 and based in London, specializes in the commercialization of intellectual property derived from research-intensive institutions. The company focuses on identifying and developing valuable intellectual property and forming strategic commercial partnerships to maximize its potential. With a strong background in industry and finance, IP Group offers financial, strategic, and commercial expertise to its clients on an international scale. The firm has established a solid track record of delivering significant results for its portfolio companies, partners, and shareholders, particularly in sectors such as pharmaceuticals and biotechnology. Through its comprehensive approach, IP Group aims to create long-term value while fostering innovation in the marketplace.

European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union. The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds; equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds. The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises. EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors. European Investment Bank was founded in 1958 and is based in Luxembourg.

Lilly Asia Ventures, established in 2008 and based in Shanghai, China, serves as the corporate venture capital arm of Eli Lilly and Company. The firm focuses on making investments in the life sciences and healthcare sectors, primarily targeting opportunities in China but also considering ventures in other parts of East and South Asia. Lilly Asia Ventures seeks to invest in companies at various stages, from seed to later stages, with a preference for those showcasing strong management teams and innovative technologies or business models. The investment strategy emphasizes human therapeutics, medical technology, healthcare services, and broader life sciences. Typically, investments range from $5 million to $15 million per round, with an inclination towards acquiring minority stakes, usually under 20 percent. The firm aims to play an active role in its portfolio companies by seeking board seats or observation rights.

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Insignia Ventures Partners is a Singapore-based venture capital firm founded in 2017, managed by Yinglan Tan, a former partner at Sequoia Asia. The firm focuses on early-stage investments across a wide range of sectors, including B2B, e-commerce, consumer goods, cryptocurrency, education, enterprise technology, fintech, gaming, healthcare, logistics, marketplace, and property technology. By targeting innovative startups, Insignia Ventures aims to support the growth of technology-driven companies in the region.

Y Combinator is a startup accelerator based in Mountain View, California, founded in 2005. It has pioneered a new funding model for early-stage startups by investing a modest amount of capital, typically around $150,000, in a large number of companies twice a year. Over a three-month program, Y Combinator collaborates closely with these startups to prepare them for investor pitches and enhance their business strategies. Each funding cycle concludes with Demo Day, where startups present to an exclusive audience of investors. Y Combinator focuses on various sectors, including business software, education, healthcare, and financial technology, among others. In addition to initial funding, it offers ongoing support through its extensive alumni network. Since its inception, Y Combinator has funded over 630 startups, contributing significantly to the entrepreneurial ecosystem in Silicon Valley and beyond.

Techstars Central LLC, founded in 2006 and based in Boulder, Colorado, operates as a startup accelerator and venture capital firm focused on supporting early-stage technology-oriented companies. It specializes in a mentorship-driven accelerator program, selecting ten startups each summer to participate in a three-month incubation period, offering funding of $120,000 in exchange for equity. Techstars invests primarily in sectors such as fintech, artificial intelligence, blockchain, augmented reality, and IoT, while avoiding investments in medical devices, healthcare technology, and local service-oriented businesses. In addition to its primary accelerator, Techstars has various specialized programs, including those focused on music, retail, mobility, and social impact, with global reach extending to regions such as Africa, Asia, and Latin America. The firm prefers taking minority stakes, typically between six and ten percent, without seeking board representation or investor rights. Techstars has built a robust network of entrepreneurs, mentors, and corporate partners to foster innovation and growth within its portfolio, which includes over 1,000 companies with a significant collective market capitalization.

Calculus Capital Limited is a venture capital and private equity firm based in London, United Kingdom, specializing in investments in small and medium-sized companies. The firm focuses on established and mature businesses, avoiding start-ups and overseas ventures. It typically invests between £2 million and £5 million in companies exhibiting positive EBITDA and sales under £50 million. Calculus Capital has a diverse portfolio, favoring sectors such as media, energy, digital marketing, pharmaceuticals, biotechnology, and technology, among others. The firm aims to take a Board seat in its portfolio companies and generally holds investments for four to five years. Known for creating tax-efficient private equity funds, Calculus Capital has been recognized for its investment strategies and has experienced a robust pipeline of prospective investments, benefiting from supportive government policies regarding tax incentives. Founded in November 1999, Calculus Capital has established a solid track record in managing funds that offer significant growth potential while maintaining a sensible risk profile.

IPR.VC is a venture capital firm based in Helsinki, Finland, founded in 2014. The firm focuses on investing in the European digital media, communications, and entertainment sectors, specifically targeting high-quality and original content in areas such as film, television, animation, games, and internet media. IPR.VC aims to transform creators and storytellers from subcontractors into intellectual property developers and business owners, supporting the growth of a vibrant content creation ecosystem in Europe. The firm is committed to identifying productions with significant audience potential and credible international distribution plans. With a team that combines industry expertise and investment experience, IPR.VC seeks to prove to its investors that content investing can yield exceptional returns.

Earlybird Venture Capital GmbH & Co. KG is a Berlin-based venture capital firm established in 1997, focusing on early-stage and growth investments in technology and healthcare sectors. The firm typically invests in disruptive consumer and enterprise internet businesses, mobility, logistics, and various technology-driven fields such as artificial intelligence, cloud computing, and fintech. Earlybird emphasizes companies located in Europe, particularly in German-speaking countries and Central Eastern Europe, while also considering opportunities in the United States and other regions. With over €1 billion under management, Earlybird aims to provide not only financial backing but also strategic support and access to a robust international network. The firm usually invests between €200,000 and €5 million in initial funding, with the potential for follow-on investments up to €15 million per portfolio company. Known for being one of the most experienced venture investors in Europe, Earlybird has a strong track record, including seven IPOs and 23 trade sales.